Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 |
|---|---|---|
| Total Revenue | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 |
| Selling General And Administration | 3.1M | 1.6M |
| General And Administrative Expense | 2.1M | 1.4M |
| Other Operating Expenses | 6.4M | 2.0M |
| Operating Expense | 9.5M | 3.6M |
| Operating Income | -9.5M | -3.6M |
| EBIT | -9.2M | -3.7M |
| Interest Expense | 805.00 | 2,500 |
| Interest Expense Non Operating | 805.00 | 2,500 |
| Interest Income | 373,196 | 25,964 |
| Interest Income Non Operating | 373,196 | 25,964 |
| Net Interest Income | 372,391 | 23,464 |
| Other Income Expense | -35,412 | -49,878 |
| Special Income Charges | 0.00 | -57,583 |
| Write Off | 0.00 | 57,583 |
| Gain On Sale Of Security | -14,009 | -25,296 |
| Earnings From Equity Interest | -21,403 | 33,001 |
| Pretax Income | -9.2M | -3.7M |
| Tax Effect Of Unusual Items | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -9.2M | -3.7M |
| Net Income From Continuing Operation Net Minority Interest | -9.2M | -3.7M |
| Net Income Including Noncontrolling Interests | -9.2M | -3.7M |
| Net Income Common Stockholders | -9.2M | -3.7M |
| Net Income | -9.2M | -3.7M |
| EBITDA | -9.2M | -3.7M |
| Normalized EBITDA | -9.2M | -3.6M |
| Basic EPS | -0.06 | -0.03 |
| Diluted EPS | -0.06 | -0.03 |
| Basic Average Shares | 162.7M | 122.2M |
| Diluted Average Shares | 162.7M | 122.2M |
| Total Unusual Items | -14,009 | -82,879 |
| Total Unusual Items Excluding Goodwill | -14,009 | -82,879 |
| Tax Rate For Calcs | 0.00 | 0.00 |
| Normalized Income | -9.2M | -3.6M |
| Diluted NI Availto Com Stockholders | -9.2M | -3.7M |
| Net Income Continuous Operations | -9.2M | -3.7M |
| Net Non Operating Interest Income Expense | 372,391 | 23,464 |
| Other Gand A | 571,911 | 501,692 |
| Salaries And Wages | 1.5M | 930,743 |
| Selling And Marketing Expense | 993,735 | 213,967 |
| Total Expenses | 9.5M | 3.6M |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 |
|---|---|---|
| Cash And Cash Equivalents | 11.2M | 1.2M |
| Cash Cash Equivalents And Short Term Investments | 11.2M | 1.2M |
| Cash Financial | 11.2M | 1.2M |
| Accounts Receivable | 25,309 | 15,588 |
| Receivables | 25,309 | 15,588 |
| Other Current Assets | 750,964 | 294,636 |
| Current Assets | 12.0M | 1.5M |
| Net PPE | 7.9M | 6.7M |
| Investments And Advances | 100,588 | 121,991 |
| Long Term Equity Investment | 100,588 | 121,991 |
| Other Non Current Assets | 98,866 | 174,344 |
| Total Non Current Assets | 8.1M | 7.0M |
| Total Assets | 20.1M | 8.5M |
| Current Debt | -- | 52,100 |
| Current Debt And Capital Lease Obligation | -- | 52,100 |
| Accounts Payable | 2.0M | 1.2M |
| Payables | 2.0M | 1.2M |
| Payables And Accrued Expenses | 2.0M | 1.2M |
| Current Liabilities | 2.2M | 1.3M |
| Total Non Current Liabilities Net Minority Interest | 222,105 | 169,975 |
| Total Liabilities Net Minority Interest | 2.5M | 1.5M |
| Common Stock | 34.4M | 18.4M |
| Capital Stock | 34.4M | 18.4M |
| Retained Earnings | -20.8M | -11.6M |
| Gains Losses Not Affecting Retained Earnings | 4.1M | 238,673 |
| Other Equity Adjustments | 4.1M | 238,673 |
| Common Stock Equity | 17.6M | 7.0M |
| Stockholders Equity | 17.6M | 7.0M |
| Total Equity Gross Minority Interest | 17.6M | 7.0M |
| Total Capitalization | 17.6M | 7.0M |
| Net Tangible Assets | 17.6M | 7.0M |
| Tangible Book Value | 17.6M | 7.0M |
| Working Capital | 9.8M | 198,483 |
| Invested Capital | 17.6M | 7.1M |
| Total Debt | -- | 52,100 |
| Share Issued | 177.3M | -- |
| Ordinary Shares Number | 177.3M | -- |
| Current Notes Payable | 0.00 | 52,100 |
| Current Provisions | 222,273 | -- |
| Long Term Provisions | 222,105 | -- |
| Non Current Accrued Expenses | 0.00 | 169,975 |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 |
|---|---|---|
| Operating Cash Flow | -8.6M | -3.6M |
| Cash Flow From Continuing Operating Activities | -8.6M | -3.6M |
| Stock Based Compensation | 812,535 | 0.00 |
| Change In Working Capital | 122,251 | 98,620 |
| Changes In Account Receivables | -9,721 | 16,954 |
| Change In Receivables | -9,721 | 16,954 |
| Change In Payables And Accrued Expense | 487,934 | 178,599 |
| Other Non Cash Items | -370,772 | -23,464 |
| Capital Expenditure | -174,280 | -165,748 |
| Purchase Of PPE | -174,280 | -165,748 |
| Net PPE Purchase And Sale | -174,280 | -165,748 |
| Investing Cash Flow | 198,916 | -139,784 |
| Cash Flow From Continuing Investing Activities | 198,916 | -139,784 |
| Issuance Of Debt | 0.00 | 75,000 |
| Repayment Of Debt | -52,905 | 0.00 |
| Net Issuance Payments Of Debt | -52,905 | 75,000 |
| Issuance Of Capital Stock | 18.4M | 4.5M |
| Net Common Stock Issuance | 18.4M | 4.5M |
| Financing Cash Flow | 18.4M | 4.6M |
| Cash Flow From Continuing Financing Activities | 18.4M | 4.6M |
| Effect Of Exchange Rate Changes | 40,133 | -1,503 |
| Changes In Cash | 10.0M | 871,442 |
| Beginning Cash Position | 1.2M | 300,862 |
| End Cash Position | 11.2M | 1.2M |
| Free Cash Flow | -8.8M | -3.7M |
| Income Tax Paid Supplemental Data | 0.00 | 0.00 |
| Interest Paid Supplemental Data | 2,905 | 0.00 |
| Asset Impairment Charge | 0.00 | 57,583 |
| Change In Prepaid Assets | -355,962 | -96,933 |
| Common Stock Issuance | 18.4M | 4.5M |
| Gain Loss On Investment Securities | 21,403 | -33,001 |
| Gain Loss On Sale Of Business | 21,403 | -33,001 |
| Interest Received Cfi | 373,196 | 25,964 |
| Net Foreign Currency Exchange Gain Loss | -14,442 | 11,715 |
| Net Income From Continuing Operations | -9.2M | -3.7M |
| Net Short Term Debt Issuance | -52,905 | 75,000 |
| Operating Gains Losses | 6,961 | -21,286 |
| Proceeds From Stock Option Exercised | 20,000 | 0.00 |
| Provisionand Write Offof Assets | 1,619 | 0.00 |
| Short Term Debt Issuance | 0.00 | 75,000 |
| Short Term Debt Payments | -52,905 | 0.00 |